Personalized Medicine in Skull Base and Sinonasal Tumors
- PMID: 36556204
- PMCID: PMC9784792
- DOI: 10.3390/jpm12121983
Personalized Medicine in Skull Base and Sinonasal Tumors
Abstract
Skull base and sinonasal tumors (SBSNTs) represent a considerable challenge for clinicians in view of their rarity, anatomical complexity of the site of origin, and great histological variety [...].
Conflict of interest statement
The authors declare no conflict of interest.
References
-
- Amit M., Abdelmeguid A.S., Watcherporn T., Takahashi H., Tam S., Bell D., Ferrarotto R., Glisson B., Kupferman M.E., Roberts D.B., et al. Induction Chemotherapy Response as a Guide for Treatment Optimization in Sinonasal Undifferentiated Carcinoma. J. Clin. Oncol. 2019;37:504–512. doi: 10.1200/JCO.18.00353. - DOI - PMC - PubMed
-
- Glöss S., Jurmeister P., Thieme A., Schmid S., Cai W.Y., Serrette R.N., Perner S., Ribbat-Idel J., Pagenstecher A., Bläker H., et al. IDH2 R172 Mutations Across Poorly Differentiated Sinonasal Tract Malignancies: Forty Molecularly Homogenous and Histologically Variable Cases with Favorable Outcome. Am. J. Surg. Pathol. 2021;45:1190–1204. doi: 10.1097/PAS.0000000000001697. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources